연구성과로 돌아가기

2024 연구성과별 연구자 정보 (1644 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Suarez, Cristina Suárez, C 13 Hosp Univ Vall Hebron, Med Oncol, Vall dHebron Inst, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Chang, Chao-Hsiang Chang, CH 14 China Med Univ Hosp, Dept Urol, Taichung, Taiwan thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Chang, Chao-Hsiang Chang, CH 14 China Med Univ, Coll Chinese Med, Sch Med, Taichung, Taiwan thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Roghmann, Florian Roghmann, F 15 Ruhr Univ Bochum, Marien Hosp Herne, Dept Urol, Herne, Germany AHA-1003-2022 Roghmann, Florian thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Ozguroglu, Mustafa Özgüroglu, M 16 Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Istanbul, Turkiye thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Eigl, Bernhard J. Eigl, BJ 17 BC Canc Vancouver, Vancouver, BC, Canada thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Oliveira, Niara Oliveira, N 18 Mater Hosp Brisbane, Mater Misericordiae, Brisbane, Qld, Australia thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Oliveira, Niara Oliveira, N 18 Univ Queensland, Mater Clin Unit, Sch Clin Med, Brisbane, Qld, Australia thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Buchler, Tomas Buchler, T 19 Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Buchler, Tomas Buchler, T 19 Thomayer Hosp, Prague, Czech Republic thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Gadot, Moran Gadot, M 20 Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Gadot, Moran Gadot, M 20 Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Zakharia, Yousef Zakharia, Y 21 Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Armstrong, Jon Armstrong, J 22 AstraZeneca, Cambridge, England thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Gupta, Ashok Gupta, A 23 AstraZeneca, New York, NY USA thomas.powles1@nhs.net;
페이지 이동: